Skip to main content
TipRanks
Go Ultimate75% OFF

Crescent Biopharma (CBIO) Q3 2023 Earnings Report

1,027 Followers

CBIO Q3 2023 EPS Results

Actual EPS
-$14.00
Consensus EPS
-$14.33
Beat/Miss
Beat by +$0.33
One Year Ago EPS
-$16.00

CBIO Q3 2023 Revenue Results

Actual Revenue
$0
Expected Revenue
$0
Beat/Miss
Met expectations
YoY Revenue Growth
―

Earnings Announcement Details

Quarter
Q3 2023
Date
11/03/2023
Time
Before Open
Conference Call
Friday, November 3, 2023
CBIO Upcoming Earnings

Crescent Biopharma's next earnings date is estimated for March 4, 2027, based on past reporting schedules.

Q3 2023 Earnings Call Audio

CBIO Q3 2023 Earnings Call
0:00 / 0:00

Q3 2023 Earnings Slide Deck

No slide deck is available for this earnings event.

Q3 2023 Earnings Call Summary

No earnings call summary is available for this earnings event.

CBIO Earnings History

CBIO earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Mar 04, 20272026 (Q4)-0.82--4.01――
Nov 12, 20262026 (Q3)-0.69-0.90-1.2729.13% (+0.37)
Jul 30, 20262026 (Q2)-0.74-0.74-4.9384.99% (+4.19)
Apr 29, 20262026 (Q1)-0.88-0.70-17.8296.07% (+17.12)
Feb 26, 20262025 (Q4)-2.47-4.01-849.88% (+3.99)
Nov 06, 20252025 (Q3)-1.96-1.27-360.3799.65% (+359.10)
Jul 31, 20252025 (Q2)-1.67-4.93-15.6668.51% (+10.73)
May 01, 20252025 (Q1)-0.05-0.05-0.1770.59% (+0.12)
Feb 27, 20252024 (Q4)-0.08-0.11-0.1420.00% (+0.03)
Nov 07, 20242024 (Q3)-0.11-0.15-0.14-8.57% (-0.01)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed